SPRI Methodology
Solid Phase Reversible Immobilization (SPRI) technology uses paramagnetic beads to selectively bind nucleic acids by type and size.
SPRI beads are directly added to sample reactions.
Nucleic acids are selectively immobilized onto SPRI beads, leaving contaminants in solution.
A magnetic field is used to pull the microparticles out of solution.
Contaminants are aspirated and microparticles are thoroughly washed, yielding high quality nucleic acids.
Purified nucleic acids are easily eluted from the microparticles under aqueous conditions, which provides maximum flexibility for downstream applications.
及时从贝克曼库尔特生命科学专家那里获得您感兴趣的信息。
© 2000-2025 贝克曼库尔特国际贸易(上海)有限公司保留最终解释权
NOT ALL PRODUCTS ARE AVAILABLE IN ALL COUNTRIES.
PRODUCT AVAILABILITY AND REGULATORY STATUS DEPENDS ON COUNTRY REGISTRATION PER APPLICABLE REGULATIONS
The listed regulatory status for products correspond to one of the below:
IVD: In Vitro Diagnostic Products. These products are labeled "For In Vitro Diagnostic Use."
ASR: Analyte Specific Reagents. These reagents are labeled "Analyte Specific Reagents. Analytical and performance characteristics are not established."
CE: Products intended for in vitro diagnostic use and conforming to European Directive (98/79/EC). (Note: Devices may be CE marked to other directives than (98/79/EC)
RUO: Research Use Only. These products are labeled "For Research Use Only. Not for use in diagnostic procedures."
LUO: Laboratory Use Only. These products are labeled "For Laboratory Use Only."
No Regulatory Status: Non-Medical Device or non-regulated articles. Not for use in diagnostic or therapeutic procedures.
沪ICP备18036651号-1
沪公网安备 31010502004935号
互联网药品信息服务资格证书(沪)-非经营性-2020-0189
沪(浦)应急管危经许[2022]200234